SUBSCRIBE
SUBSCRIBE

Elutia

NEWS
Business
Aziyo Biologics Banks Some Cash And Former Osiris Exec As Its New CEO
June 15, 2017
 · 
1 min read
IN THE PRESS
Press Releases
Elutia Awarded Cardiac Rhythm Management Devices Agreement with Premier, Inc.
December 2, 2024
 · 
5 min read
Press Releases
Elutia Announces Strong Third Quarter Results, Accelerating Toward Full Launch of EluPro® Antibiotic-Eluting BioEnvelope in 2025
November 15, 2024
 · 
14 min read
Press Releases
Elutia to Report Third Quarter 2024 Financial Results on Thursday, November 14, 2024
October 30, 2024
 · 
1 min read
Business
Elutia Announces New Peer Reviewed Publication Highlighting the Robustness of EluPro™, Company’s Antibiotic-Eluting BioEnvelope for Implantable Devices
September 18, 2024
 · 
6 min read
News
Elutia Announces First Patient Implant of EluPro™, the World’s First Drug-Eluting BioEnvelope for Cardiac Pacemakers and Neurostimulators
September 5, 2024
 · 
6 min read
Press Releases
Elutia to Participate in Upcoming Investor Conferences
September 4, 2024
 · 
1 min read
Press Releases
Elutia Announces Second Quarter 2024 Results
August 8, 2024
 · 
14 min read
Press Releases
Elutia Appoints Ryan Marques, Ph.D., MBA as Vice President of Operations
August 1, 2024
 · 
2 min read
Press Releases
Elutia to Report Second Quarter 2024 Financial Results on Wednesday, August 7, 2024
July 31, 2024
 · 
1 min read
BioCapital
Elutia Announces FDA Clearance of EluPro®: The First Antibiotic-Eluting BioEnvelope Designed to Protect Patients with Implantable Cardiac Pacemakers and Defibrillators
June 17, 2024
 · 
7 min read
Load More
JOBS